
    
      This study investigates the characteristics of cardiovascular adverse events leading to
      hospitalization in metastatic colorectal cancer. Descriptive analysis will include incidence,
      type of cardiovascular adverse events.

      We will explore the incidence of cardiovascular adverse events with regard of the
      antineoplastic drug exposures. This will provide information about the individual drug safety
      profiles.
    
  